Copyright
©2010 Baishideng.
World J Gastroenterol. Jul 7, 2010; 16(25): 3161-3167
Published online Jul 7, 2010. doi: 10.3748/wjg.v16.i25.3161
Published online Jul 7, 2010. doi: 10.3748/wjg.v16.i25.3161
Table 3 Liver function tests (mean ± SD)
| Serum test | Baseline | 1 mo | 3 mo |
| AFP (ng/mL) | 1633 ± 5997 | 5599 ± 21080 | 1264 ± 2684 |
| AST (U/L) | 62.6 ± 23.9 | 66.2 ± 32.1 | 80.7 ± 64.5 |
| ALT (U/L) | 52.6 ± 31.0 | 54.8 ± 39.1 | 53.1 ± 49.4 |
| Alkaline phosphatase (U/L) | 160 ± 75.0 | 203 ± 107 | 173 ± 68.8 |
| Total bilirubin (mg/dL) | 1.38 ± 0.644 | 1.28 ± 0.75 | 2.23 ± 2.22 |
- Citation: Chung JC, Naik NK, Lewandowski RJ, Deng J, Mulcahy MF, Kulik LM, Sato KT, Ryu RK, Salem R, Larson AC, Omary RA. Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization. World J Gastroenterol 2010; 16(25): 3161-3167
- URL: https://www.wjgnet.com/1007-9327/full/v16/i25/3161.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i25.3161